SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased investor optimism driven by a positive Medicare Advantage rate announcement and ongoing margin recovery efforts, with the community closely tracking upcoming earnings for further validation of the company's turnaround strategy. Discussions are centered on the potential for institutional accumulation, the impact of AI-driven cost efficiencies, and bullish sentiment surrounding the stock's long-term growth prospects despite lingering regulatory caution.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently gripped by a intense, high-conviction short squeeze, fueled by a significantly constrained float and concentrated ownership by institutional players. The community is actively debating the sustainability of this parabolic move, with many traders warning of extreme volatility and the potential for a swift correction once the market mechanics unwind.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a significant surge in momentum driven by aggressive institutional accumulation and anticipation of its upcoming U.S. redomicile, which investors believe will eliminate regulatory and tax-related investment hurdles. The community is actively dismissing a recent short-seller report as a failed attempt to manipulate the stock, focusing instead on the company's critical role in the optical interconnect space and its deep-tech partnerships with major semiconductor players.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following the unexpected announcement that long-time CEO Tim Cook will step down in 2026 to transition into an Executive Chairman role, with current hardware chief John Ternus tapped as his successor. Investors and community members are actively debating the leadership shift, weighing the implications for Apple's future innovation, AI strategy, and the potential for a new era under an engineering-focused CEO.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors react to the company's international expansion efforts in Japan and the Middle East, while speculating on pending FDA decisions and broader potential for its cancer therapy ANKTIVA to reverse T-cell exhaustion. The community remains heavily focused on the high short interest and the potential for a significant price squeeze, viewing the stock as a battleground between long-term retail holders and short sellers.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently experiencing heightened investor attention driven by a combination of imminent mission milestones, including two scheduled launches, and strategic expansion through the closure of its Mynaric acquisition. The community is heavily focused on the company's long-term vertical integration, its emerging role in defense-focused hypersonic testing, and its perceived positioning as a primary competitor to larger industry players as demand for space infrastructure accelerates.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing significant retail momentum and a potential short squeeze, driven by the termination of a major share dilution facility and the SEC's approval to eliminate pattern day trading restrictions. The community is actively discussing these catalysts as signs of a structural re-rating, with many bulls comparing the platform's long-term growth potential and valuation to larger peers.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is trending as investors monitor ongoing supply chain developments and the company's strong industrial backlog, while also navigating recent market-wide volatility during the latest earnings cycle. The community remains focused on the company's long-term growth narrative as a standalone aerospace entity and its role as a key player in global defense and commercial aviation infrastructure.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is gaining momentum as investors focus on its strong order backlog and defense production scale-up, supported by assertive 2026 guidance and consistent contract wins. The community remains broadly bullish, closely tracking how the company's defense-aerospace mix navigates current geopolitical demand and supply chain replenishment cycles.

Applied Digital Corporation

Applied Digital is trending as investors closely monitor an upcoming April 18th lease deadline and potential hyperscaler deal, fueling intense debate over whether news is imminent or if current price action reflects market manipulation. The community remains sharply divided between long-term bullish holders focused on AI infrastructure expansion and day traders attempting to time the stock around high-stakes technical gaps and geopolitical volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month High  - Here's What Happened

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year High - Here's Why...

Can Myqorzo Drive Growth for Cytokinetics Amid Competition?

CYTK enters the commercial stage with FDA-approved Myqorzo for oHCM, eyeing strong market share, but faces stiff competition and execution risks.

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 1-Year High - Still a Buy?

Edgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month High - Here's Why...

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month High - Should You Buy?

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month High - Here's Why...

Aberdeen Group plc Increases Position in Edgewise Therapeutics, Inc. $EWTX

Aberdeen Group plc lifted its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 32.6% during the fourth quarter, according to its most recent 13F filing with the Securities...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) have been given an average rating of "Moderate Buy" by the ten research firms that are currently covering the company, MarketBeat...

SG Americas Securities LLC Buys 78,842 Shares of Edgewise Therapeutics, Inc. $EWTX

SG Americas Securities LLC raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 797.9% during the fourth quarter, according to its most recent Form 13F filing...

Edgewise Therapeutics (NASDAQ:EWTX) CMO Sells $926,069.22 in Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) CMO Joanne Donovan sold 28,662 shares of the company's stock in a transaction on Wednesday, April 1st. The shares were sold at an average...

Edgewise Therapeutics (NASDAQ:EWTX) CMO Joanne Donovan Sells 28,662 Shares

Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) CMO Joanne Donovan sold 28,662 shares of the business's stock in a transaction dated Wednesday, April 1st. The stock was sold at an average...

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week High - Here's What Happened

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week High - Should You Buy...

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.

Current Price	$33.97
Prev Close	$34.43
Open	$34.29
Dividend Yield	0.00%
50-Day Moving Average	$30.86
Beta	1.36
Avg. Volume	891,676.51
PE Ratio	-20.81

52-Week High	$35.00
52-Week Low	$12.15
Market Capitalization	$3.69B
EPS (Annual)	-$1.63
Price to Book	6.91
Revenue Per Employee	$0.00

EWTX
Edgewise Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EWTX News

EWTXEdgewise Therapeutics Inc